Norris Medicines Ltd Board Approves FY26 Directors Report & AGM Notice

Norris Medicines Ltd announced the outcome of its Board Meeting held on September 3, 2026. The board approved the Directors Report for the Financial Year ended 2025-2026, along with related annexures. Key decisions included approving the closure of the Register of Members and Share Transfer Books for the upcoming Annual General Meeting (AGM). The company also approved the cut-off date for electronic voting entitlements and the convening of the 35th AGM on September 29, 2026, to be held via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The 35th Annual Report, including the AGM notice, was also approved. Furthermore, the board appointed Mr. Hemant Shetye as the scrutinizer for the e-voting process and Purva Sharegistry (India) Pvt. Ltd. to facilitate e-voting at the AGM. Directors and the Company Secretary were authorized to conduct the AGM and manage related documentation.